Another comment on the role of statistical methods.

the randomized control trial. Survey of 71 "negative" trials. N EnglJ Med 1978;299:690-4. 16 Cox DR. Statistical significance tests. BrJ Clin Pharmacol 1982; 14:325-31. 17 Rothman KJ. Significance questing. Ann Intern Med 1986; 105:445-7. 18 Altman DG, Gore SM, Gardner MJ, Pocock, SJ. Statistical guidelines for contributors to medical journals. BMJ 1983;286:1489-93. 19 Gardner MJ, Altman DG. Confidence intervals rather than P values: esti mation rather than hypothesis testing. BMJ 1986;292:746-50. 20 Gardner MJ, Altman DG. Statistics with confidence. Confidence intervals and statistical guidelines. London: BMJ Publishing, 1989. 21 Hopkins PN, Williams RR. Identification and relative weight of cardiovas cular risk factors. Cardiol Clin 1986;4:3-31. 22 FreimanJA, Chalmers TC, Smith H, Kuebler RR. The importance of beta, the type II error, and sample size in the design and interpretation of the randomized controlled trial. In: Bailar JC, Mosteller F, eds. Medical uses of statistics. Boston, Ma: NEJM Books, 1992:357-73. 23 Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials./__MA 1994;272:122-4. 24 Mulward S, G0tzsche PC Sample size of randomized double-blind trials 1976-1991. Dan Med Bull 1996;43:96-8. 25 Oakes M. Statistical inference. Chichester: Wiley, 1986. 26 Browner WS, Newman TB. Are all significant P values created equal? The analogy between diagnostic tests and clinical research. JAMA 1987;257:2459-63. 27 Edwards W, Lindman H, Savage LJ. Bayesian statistical inference for psy chological research. PsycholRev 1963;70:193-242. 28 Berger JO, Sellke T. Testing a point null hypothesis: the irreconcilability of P values and evidence./ Am Stat Assoc 1987;82:112-22. 29 Lilford RJ, Braunholtz D. The statistical basis of public policy: a paradigm shift is overdue. BMJ 1996;313:603-7. 30 Brophy JM, Joseph L. Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes./AMA 1995;273:871-5. 31 Burton PR, Gurrin LC, Campbell MJ. Clinical significance not statistical significance: a simple Bayesian alternative to p values./ Epidemiol Commu nity Health 1998;52:318-23. 32 Goodman SN. Toward evidence-based medical statistics. 2: The Bayes factor. Ann Intern Med 1999; 130:1005-13. 33 Phillips AN, Davey Smith G. The design of prospective epidemiological studies: more subjects or better measurements? / Clin Epidemiol 1993;46:1203-11. 34 Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med 1984;3:409-22. 35 Egger M, Davey Smith G. Meta-analysis. Potentials and promise. BMJ 1997;315:1371-4. 36 Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospec tive study and meta-analysis. BMJ 2000;321:208-13. 37 Morris JN. The uses of epidemiology. Edinburgh: Churchill-Livingstone, 1975.